Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bromodeoxyuridine (BrdU) in Prostate Cancer
NCT00003832Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 1999
- Primary completion
- Jun 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bromodeoxyuridine in prostate cancer (PCa), sponsored by National Cancer Institute. Started Jul 1999; status: completed.
02
Drugs
bromodeoxyuridine
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003832.